Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Liver Neoplasms × trastuzumab deruxtecan × Clear all

Sponsor

Conditions

Breast Neoplasms 13 Neoplasm Metastasis 8 Neoplasms 4 Carcinoma, Non-Small-Cell Lung 4 Stomach Neoplasms 3 Colorectal Neoplasms 3 Adenocarcinoma 3 Brain Neoplasms 2 Triple Negative Breast Neoplasms 1 Meningeal Carcinomatosis 1 HER2-mutant Non-Small Cell Lung Cancer 1 Gastrointestinal Neoplasms 1 Carcinoma, Transitional Cell 1

Interventions

Sorafenib 22 Bevacizumab 10 Capecitabine 6 Radiofrequency Ablation 5 Oxaliplatin 5 Fluorouracil 5 Doxorubicin 5 pembrolizumab 4 Sunitinib 4 Radiosurgery 4 Cisplatin 4 Ramucirumab 3 Radiotherapy 3 Leucovorin 3 Erlotinib Hydrochloride 3 Carboplatin 3 tremelimumab 2 spartalizumab 2 perflutren 2 derazantinib 2 carotuximab 2 Nivolumab 2 Mitomycin 2 Magnetic Resonance Spectroscopy 2 Magnetic Resonance Imaging 2 Ipilimumab 2 Immunohistochemistry 2 Gemcitabine 2 Folfox protocol 2 Fluorodeoxyglucose F18 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡